ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2019 American Transplant Congress

    Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients

    S. Hamel1, V. Johnson2, D. Johnson2, E. Blumberg3, R. Bloom4, J. Trofe-Clark2

    1Pharmacy, Vanderbilt Univ. Medical Center, Nashville, TN, 2Pharmacy, Hospital of the Univ. of Pennsylvania, Philadelphia, PA, 3Infectious Diseases, Univ. of Pennsylvania, Philadelphia, PA, 4Renal, Univ. of Pennsylvania, Philadelphia, PA

    *Purpose: Secondary options for Pneumocystis Jirovecii pneumonia (PJP) prophylaxis in kidney transplant recipients (KTRs) include atovaquone or dapsone. Atovaquone use may be limited by cost/side…
  • 2019 American Transplant Congress

    Preoperative Marginal Factors Do Not Affect the Medically Complex Living Donors for Kidney Transplantation

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai

    Nagoya Daini Red Cross Hospital, Nagoya Aichi, Japan

    *Purpose: Recently, medically complex living donors with marginal factors including hypertension, dyslipidemia, glucose intolerance, and obesity are increasing. The impact of preoperative marginal factors on…
  • 2019 American Transplant Congress

    Arterial Blood Pressure Circadian Rhythm in Renal Transplant Recipients

    A. M. Arriaga, Y. J. Lopez, J. A. Cedillo, L. A. Marino, J. M. Mejia, I. Parra, A. Cohen, L. E. Morales

    Nephrology, National Institute of Medical Sciences and Nutrition Salvador Zubirán,, Mexico City, Mexico

    *Purpose: Approximately 80% kidney transplant (KT) recipients have high blood pressure, compromising graft survival and increasing cardiovascular risk. In the pre-transplant stage, alterations in blood…
  • 2019 American Transplant Congress

    Patients with Immunological Diseases or on Peritoneal Dialysis Are Prone to False Positive Flow Cytometry Cross Match

    Q. Xu1, A. House2, S. Leckie1, L. Gunaratnam2, P. Luke3, A. Jevnikar2

    1Pathology and Lab Medicine, London Health Science Center, London, ON, Canada, 2Medicine, Western University, London, ON, Canada, 3Surgery, Western University, London, ON, Canada

    *Purpose: Despite implementation of virtual cross matches, flow cytometry cross matches (FCXM) are still used by many transplant centers to determine immunological risk prior to…
  • 2019 American Transplant Congress

    Contemporary Predictors and Impact on Survival of Early Readmission after Kidney Transplant: Analysis of the Nationwide Readmission Database

    N. Elfadawy, N. Tashtish, S. Al-kindi, D. Hricik, E. Sanchez, N. Sarabu

    University hospitals of Cleveland, Cleveland, OH

    *Purpose: Thirty-day readmissions after kidney transplantation are common and contribute to healthcare utilization and costs. We sought to describe the rates, causes, and predictors for…
  • 2019 American Transplant Congress

    Impact of Acute Kidney Injury in Elderly Deceased Donor on the Post-Transplant Clinical Outcomes

    J. Kim1, J. Lee2, Y. Kim3, K. Jin4, S. Han4, Y. Hong1, Y. Chang1, S. Kim1, H. Yoon5, C. Yang2, W. Park4, B. Chung2

    1Internal Medicine, Daejeon St. Mary`s Hospital, Daejeon, Korea, Republic of, 2Internal Medicine, Seoul St. Mary`s Hospital, Seoul, Korea, Republic of, 3Internal Medicine, Uijeongbu St. Mary`s Hospital, Uijeongbu, Korea, Republic of, 4Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of, 5Internal Medicine, Incheon St. Mary`s Hospital, Incheon, Korea, Republic of

    *Purpose: The proportion of kidney transplantation (KT) from deceased donors (DDs) with acute kidney injury (AKI) or aged more than 60 has increased, but it…
  • 2019 American Transplant Congress

    Pre Transplant Intact FGF 23 Modifies Post-Transplant Improvement in Cognition

    J. A. Klein1, A. Jurgensen1, J. Stubbs1, P. Rowe1, D. Cibrik1, W. Brooks2, J. Burns3, Z. Lauer4, A. Gupta1

    1Nephrology, University of Kansas Medical Center, Kansas City, KS, 2KU Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, 3Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, 4Internal Medicine, University of Kansas Medical Center, Kansas City, KS

    *Purpose: Fibroblast growth factor 23 (FGF23) has been associated with cognitive impairment in ESRD. Both FGF23 levels and cognition improve post-kidney transplantation (KT). It is…
  • 2019 American Transplant Congress

    The Molecular Pathology of Immune Checkpoint Inhibitor-Associated Renal Allograft Rejection: Overlap with Acute Interstitial Nephritis

    B. Adam1, C. Boils2, L. Bu3, K. Renaudin4, K. Wen1, M. Mengel1

    1University of Alberta, Edmonton, AB, Canada, 2Arkana Labs, Little Rock, AR, 3University of Minnesota, Minneapolis, MN, 4CHU Nantes, Nantes, France

    *Purpose: The use of immune checkpoint inhibitors (ICIs) for various malignancies has been associated with numerous immunological adverse events, including acute interstitial nephritis (AIN) in…
  • 2019 American Transplant Congress

    Prevention of Diabetic Nephropathy after Kidney Transplantation Requires More Than Pursuing Low Levels of Glycated Hemoglobin

    M. Coemans, E. Van Loon, E. Lerut, D. Kuypers, B. Sprangers, P. Gillard, C. Mathieu, G. Verbeke, M. Naesens

    KU Leuven, Leuven, Belgium

    *Purpose: Diabetic nephropathy is the leading cause of end-stage renal disease and progresses in five stages. During the second stage, morphologic lesions develop, without signs…
  • 2019 American Transplant Congress

    Rituximab Protects against Development of Atherosclerotic Cardiovascular Disease after Kidney Transplantation, a Propensity Matched Analysis

    D. Kim, J. Lee, J. Lee, B. Kim, M. Kim, S. Soon Il, Y. Kim, K. Huh, S. Kim, D. Joo, K. In, E. Kim

    Severance hospital, Seoul, Korea, Republic of

    *Purpose: Recent studies have implicated B cells in atherosclerosis and have verified the atheroprotective effect of rituximab. We sought to explore the effects of rituximab…
  • « Previous Page
  • 1
  • …
  • 199
  • 200
  • 201
  • 202
  • 203
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences